Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis

Hannah P. Yang, Sallie Smith Schneider, Christina M. Chisholm, Eva P. Browne, Sidra Mahmood, Gretchen L. Gierach, Sarah Lenington, Douglas L. Anderton, Mark E. Sherman, Kathleen F. Arcaro

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: TGF-β plays a dual role in breast carcinogenesis, acting at early stages as tumor-suppressors and later as tumor-promoters. TGF-β isoforms are expressed in breast tissues and secreted in milk, suggesting that analysis of levels in milk might be informative for breast cancer risk. Accordingly, we assessed TGF-β2 levels in milk from women who had undergone a breast biopsy and related the concentrations to diagnosis. Methods: Milk donated by women who had undergone or were scheduled for a breast biopsy was shipped on ice for processing and testing. Breast cancer risk factors were obtained through a self-administered questionnaire, and biopsy diagnoses were extracted from pathology reports. TGF-β2 levels in milk, assessed as absolute levels and in relation to total protein, were analyzed in bilateral samples donated by 182 women. Linear regression was used to estimate relationships of log-transformed TGF-β2 levels and TGF-β2/ total protein ratios to biopsy category. Results: Milk TGF-β2 levels from biopsied and non-biopsied breasts within women were highly correlated (r2 = 0.77). Higher mean TGF-β2 milk levels (based on average of bilateral samples) were marginally associated with more severe breast pathological diagnosis, after adjusting for duration of nursing current child (adjusted p trend = 0.07). Conclusions: Our exploratory analysis suggests a borderline significant association between higher mean TGF-β2 levels in breast milk and more severe pathologic diagnoses. Further analysis of TGF-β signaling in milk may increase understanding of postpartum remodeling and advance efforts to analyze milk as a means of assessing risk of breast pathology.

Original languageEnglish (US)
Pages (from-to)345-354
Number of pages10
JournalCancer Causes and Control
Volume26
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Human Milk
Milk
Breast
Biopsy
Pathology
Breast Neoplasms
Ice
Carcinogens
Postpartum Period
Linear Models
Protein Isoforms
Carcinogenesis
Proteins
Nursing

Keywords

  • Breast cancer
  • Breast milk
  • Epidemiology
  • TGF-β2

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Yang, H. P., Schneider, S. S., Chisholm, C. M., Browne, E. P., Mahmood, S., Gierach, G. L., ... Arcaro, K. F. (2015). Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis. Cancer Causes and Control, 26(3), 345-354. https://doi.org/10.1007/s10552-014-0498-8

Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis. / Yang, Hannah P.; Schneider, Sallie Smith; Chisholm, Christina M.; Browne, Eva P.; Mahmood, Sidra; Gierach, Gretchen L.; Lenington, Sarah; Anderton, Douglas L.; Sherman, Mark E.; Arcaro, Kathleen F.

In: Cancer Causes and Control, Vol. 26, No. 3, 2015, p. 345-354.

Research output: Contribution to journalArticle

Yang, HP, Schneider, SS, Chisholm, CM, Browne, EP, Mahmood, S, Gierach, GL, Lenington, S, Anderton, DL, Sherman, ME & Arcaro, KF 2015, 'Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis', Cancer Causes and Control, vol. 26, no. 3, pp. 345-354. https://doi.org/10.1007/s10552-014-0498-8
Yang, Hannah P. ; Schneider, Sallie Smith ; Chisholm, Christina M. ; Browne, Eva P. ; Mahmood, Sidra ; Gierach, Gretchen L. ; Lenington, Sarah ; Anderton, Douglas L. ; Sherman, Mark E. ; Arcaro, Kathleen F. / Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis. In: Cancer Causes and Control. 2015 ; Vol. 26, No. 3. pp. 345-354.
@article{65ca90adb4a947c18380882f863907e8,
title = "Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis",
abstract = "Purpose: TGF-β plays a dual role in breast carcinogenesis, acting at early stages as tumor-suppressors and later as tumor-promoters. TGF-β isoforms are expressed in breast tissues and secreted in milk, suggesting that analysis of levels in milk might be informative for breast cancer risk. Accordingly, we assessed TGF-β2 levels in milk from women who had undergone a breast biopsy and related the concentrations to diagnosis. Methods: Milk donated by women who had undergone or were scheduled for a breast biopsy was shipped on ice for processing and testing. Breast cancer risk factors were obtained through a self-administered questionnaire, and biopsy diagnoses were extracted from pathology reports. TGF-β2 levels in milk, assessed as absolute levels and in relation to total protein, were analyzed in bilateral samples donated by 182 women. Linear regression was used to estimate relationships of log-transformed TGF-β2 levels and TGF-β2/ total protein ratios to biopsy category. Results: Milk TGF-β2 levels from biopsied and non-biopsied breasts within women were highly correlated (r2 = 0.77). Higher mean TGF-β2 milk levels (based on average of bilateral samples) were marginally associated with more severe breast pathological diagnosis, after adjusting for duration of nursing current child (adjusted p trend = 0.07). Conclusions: Our exploratory analysis suggests a borderline significant association between higher mean TGF-β2 levels in breast milk and more severe pathologic diagnoses. Further analysis of TGF-β signaling in milk may increase understanding of postpartum remodeling and advance efforts to analyze milk as a means of assessing risk of breast pathology.",
keywords = "Breast cancer, Breast milk, Epidemiology, TGF-β2",
author = "Yang, {Hannah P.} and Schneider, {Sallie Smith} and Chisholm, {Christina M.} and Browne, {Eva P.} and Sidra Mahmood and Gierach, {Gretchen L.} and Sarah Lenington and Anderton, {Douglas L.} and Sherman, {Mark E.} and Arcaro, {Kathleen F.}",
year = "2015",
doi = "10.1007/s10552-014-0498-8",
language = "English (US)",
volume = "26",
pages = "345--354",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis

AU - Yang, Hannah P.

AU - Schneider, Sallie Smith

AU - Chisholm, Christina M.

AU - Browne, Eva P.

AU - Mahmood, Sidra

AU - Gierach, Gretchen L.

AU - Lenington, Sarah

AU - Anderton, Douglas L.

AU - Sherman, Mark E.

AU - Arcaro, Kathleen F.

PY - 2015

Y1 - 2015

N2 - Purpose: TGF-β plays a dual role in breast carcinogenesis, acting at early stages as tumor-suppressors and later as tumor-promoters. TGF-β isoforms are expressed in breast tissues and secreted in milk, suggesting that analysis of levels in milk might be informative for breast cancer risk. Accordingly, we assessed TGF-β2 levels in milk from women who had undergone a breast biopsy and related the concentrations to diagnosis. Methods: Milk donated by women who had undergone or were scheduled for a breast biopsy was shipped on ice for processing and testing. Breast cancer risk factors were obtained through a self-administered questionnaire, and biopsy diagnoses were extracted from pathology reports. TGF-β2 levels in milk, assessed as absolute levels and in relation to total protein, were analyzed in bilateral samples donated by 182 women. Linear regression was used to estimate relationships of log-transformed TGF-β2 levels and TGF-β2/ total protein ratios to biopsy category. Results: Milk TGF-β2 levels from biopsied and non-biopsied breasts within women were highly correlated (r2 = 0.77). Higher mean TGF-β2 milk levels (based on average of bilateral samples) were marginally associated with more severe breast pathological diagnosis, after adjusting for duration of nursing current child (adjusted p trend = 0.07). Conclusions: Our exploratory analysis suggests a borderline significant association between higher mean TGF-β2 levels in breast milk and more severe pathologic diagnoses. Further analysis of TGF-β signaling in milk may increase understanding of postpartum remodeling and advance efforts to analyze milk as a means of assessing risk of breast pathology.

AB - Purpose: TGF-β plays a dual role in breast carcinogenesis, acting at early stages as tumor-suppressors and later as tumor-promoters. TGF-β isoforms are expressed in breast tissues and secreted in milk, suggesting that analysis of levels in milk might be informative for breast cancer risk. Accordingly, we assessed TGF-β2 levels in milk from women who had undergone a breast biopsy and related the concentrations to diagnosis. Methods: Milk donated by women who had undergone or were scheduled for a breast biopsy was shipped on ice for processing and testing. Breast cancer risk factors were obtained through a self-administered questionnaire, and biopsy diagnoses were extracted from pathology reports. TGF-β2 levels in milk, assessed as absolute levels and in relation to total protein, were analyzed in bilateral samples donated by 182 women. Linear regression was used to estimate relationships of log-transformed TGF-β2 levels and TGF-β2/ total protein ratios to biopsy category. Results: Milk TGF-β2 levels from biopsied and non-biopsied breasts within women were highly correlated (r2 = 0.77). Higher mean TGF-β2 milk levels (based on average of bilateral samples) were marginally associated with more severe breast pathological diagnosis, after adjusting for duration of nursing current child (adjusted p trend = 0.07). Conclusions: Our exploratory analysis suggests a borderline significant association between higher mean TGF-β2 levels in breast milk and more severe pathologic diagnoses. Further analysis of TGF-β signaling in milk may increase understanding of postpartum remodeling and advance efforts to analyze milk as a means of assessing risk of breast pathology.

KW - Breast cancer

KW - Breast milk

KW - Epidemiology

KW - TGF-β2

UR - http://www.scopus.com/inward/record.url?scp=84925497501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925497501&partnerID=8YFLogxK

U2 - 10.1007/s10552-014-0498-8

DO - 10.1007/s10552-014-0498-8

M3 - Article

C2 - 25604865

AN - SCOPUS:84925497501

VL - 26

SP - 345

EP - 354

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 3

ER -